Table 1 Characteristics of experimental groups (n = 4, respectively).
Group | Composition of scaffold |
|---|---|
Control | No scaffold |
PCL/TCP | PCL (70 wt%)/β-TCP (30 wt%) |
PCL/TCP/BMP2 | PCL (70 wt%)/β-TCP (30 wt%)/rhBMP-2 50 μg/ml |
PCL/TCP/ABP | PCL (70 wt%)/β-TCP (30 wt%)/autogenous bone particles |
